Co-Diagnostics, Inc. Earnings Per Share, Basic and Diluted
Co-Diagnostics, Inc. (CODX) reported Earnings Per Share, Basic and Diluted of -$0.05 per share for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-05-14
- Co-Diagnostics, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.05.
- Co-Diagnostics, Inc. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$0.10.
- Co-Diagnostics, Inc. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.10.
- Co-Diagnostics, Inc. earnings per share, basic and diluted for the quarter ending 2019-06-30 was -$0.08.
- Co-Diagnostics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.36.
- Co-Diagnostics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.50.
- Co-Diagnostics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$0.63.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$0.05 10-Q · filed 2020-05-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.32 derived: net income ÷ weighted average shares · filed 2021-11-12 |
| 2019-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.21 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.28 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.36 10-K · filed 2020-03-30 |
| 2019-09-30 | -$0.10 10-Q · filed 2019-11-12 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.27 10-Q · filed 2019-11-12 | -$0.40 derived: net income ÷ weighted average shares · filed 2020-11-16 |
| 2019-06-30 | -$0.08 10-Q · filed 2019-08-14 | -$0.16 10-Q · filed 2019-08-14 | -$0.30 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.43 derived: net income ÷ weighted average shares · filed 2020-11-16 |
| 2019-03-31 | -$0.09 10-Q · filed 2020-05-14 | -$0.23 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.36 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.47 derived: net income ÷ weighted average shares · filed 2020-11-16 |
| 2018-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.28 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.40 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.50 10-K · filed 2020-03-30 |
| 2018-09-30 | -$0.13 10-Q · filed 2019-11-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$0.35 10-Q · filed 2019-11-12 | -$0.47 derived: net income ÷ weighted average shares · filed 2019-11-12 |
| 2018-06-30 | -$0.11 10-Q · filed 2019-08-14 | -$0.22 10-Q · filed 2019-08-14 | -$0.34 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$0.66 derived: net income ÷ weighted average shares · filed 2019-11-12 |
| 2018-03-31 | -$0.11 10-Q · filed 2019-05-14 | -$0.23 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$0.65 derived: net income ÷ weighted average shares · filed 2019-11-12 |
| 2017-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2019-04-01 | -$0.45 derived: net income ÷ weighted average shares · filed 2019-04-01 | -$0.55 derived: net income ÷ weighted average shares · filed 2019-04-01 | -$0.63 10-K · filed 2019-04-01 |
| 2017-09-30 | -$0.33 10-Q · filed 2018-11-14 | -$0.44 derived: net income ÷ weighted average shares · filed 2018-11-14 | -$0.52 10-Q · filed 2018-11-14 | -$0.58 derived: net income ÷ weighted average shares · filed 2018-11-14 |
| 2017-06-30 | -$0.09 derived: net income ÷ weighted average shares · filed 2018-08-10 | -$0.16 derived: net income ÷ weighted average shares · filed 2018-08-10 | -$0.21 derived: net income ÷ weighted average shares · filed 2018-08-10 | -$0.26 derived: net income ÷ weighted average shares · filed 2018-08-10 |
| 2017-03-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2018-05-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2018-05-14 | -$0.17 derived: net income ÷ weighted average shares · filed 2018-05-14 | -$0.21 derived: net income ÷ weighted average shares · filed 2018-05-14 |
| 2016-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-03-28 | -$0.10 derived: net income ÷ weighted average shares · filed 2018-03-28 | -$0.14 derived: net income ÷ weighted average shares · filed 2018-03-28 | -$0.20 derived: net income ÷ weighted average shares · filed 2018-03-28 |
| 2016-09-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2017-11-14 | -$0.09 derived: net income ÷ weighted average shares · filed 2017-11-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2017-11-14 | |
| 2016-06-30 | -$0.04 derived: net income ÷ weighted average shares · filed 2017-08-25 | -$0.10 derived: net income ÷ weighted average shares · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |